PTH and chronic kidney disease: Radioiodine therapy will be considered for hyperfunctioning ETT. The potential resection of the ETT via thoracoscopic surgery will be prioritized for symptomatic or suspicious cases, while medical management will focus on controlling thyroid and parathyroid hormone levels to attenuate CKD impact.